| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
William H McCall last filed a Form 4 in December 2024, as Director at SRTS. William H McCall's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 30,000 shares of SRTS. The SRTS filings lean toward selling, a net 10,000 shares.
William H McCall has 6 Form 4 filings on record from June 2016 to December 2024, all as Director at Sensus Healthcare (SRTS), 2016–2024.
The 7 reported transactions were 3 stock awards, 2 open-market sales, 1 other transaction and 1 option exercise.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $75K.
The only open-market sale was 10,000 shares of SRTS at an average $7.54 on May 10, 2022, about $75K. Twelve months later SRTS was down 62%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2022 | SRTS Sensus Healthcare, Inc. | Director | Sell | 10,000 | $7.54 | $75,400.00 | -3.0% | +80.3% | -61.7% |